FDA Approves Dual-Energy Catheter Ablation Platform - Takeaways - MDSpire

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.

  • By

  • Kathryn Wighton

  • July 8, 2026

  • 2 min

Share

  • 1

    The FDA has approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform from Johnson & Johnson for catheter ablation.

  • 2

    This platform allows electrophysiologists to deliver both pulsed field and radiofrequency energy through a single catheter.

  • 3

    The platform is built on the existing THERMOCOOL SMARTTOUCH SF catheter platform, used in over one million US patient treatments.

  • 4

    The Dual Energy platform integrates with the CARTO ecosystem for enhanced mapping, imaging, and guidance.

  • 5

    First US procedures using the platform are expected to begin this summer as part of a phased commercial rollout.

Original Source(s)

FDA Approves Dual-Energy Catheter Ablation Platform

  • by Kathryn Wighton

  • July 8, 2026

Related Content

Hemodynamic Instability in Intubation May Be Predictable

Narrative review describes how physiologic stressors accumulate from induction through postintubation care and may contribute to cardiovascular deterioration during airway management.

Segmental analysis of left atrial substrate severity predictors in patients undergoing persistent atrial fibrillation ablation

Ambulatory Fetal Heart Rate and Rhythm Monitoring for Pregnancies at Risk for Fetal Arrhythmias: Perspectives from the Fetal Heart Society